Ontology highlight
ABSTRACT:
INSTRUMENT(S): timsTOF Pro
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Brain
DISEASE(S): Brain Glioma
SUBMITTER: Peisen yao
LAB HEAD: Dezhi Kang
PROVIDER: PXD027864 | Pride | 2022-02-17
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
Ac_CA1_1_Slot1-34_1_8388.d.zip | Other | |||
Ac_CA1_2_Slot1-35_1_8390.d.zip | Other | |||
Ac_CA1_3_Slot1-36_1_8392.d.zip | Other | |||
Ac_CA2_1_Slot1-37_1_8394.d.zip | Other | |||
Ac_CA2_2_Slot1-38_1_8396.d.zip | Other |
Items per page: 5 1 - 5 of 7 |
Xu Ya-Wen YW Lin Peng P Zheng Shu-Fa SF Huang Wen W Lin Zhang-Ya ZY Shang-Guan Huang-Cheng HC Lin Yuan-Xiang YX Yao Pei-Sen PS Kang De-Zhi DZ
Frontiers in neurology 20211001
<b>Objective:</b> We test the hypothesis that lysine acetylation is involved in the metabolic process of glioma-associated seizures (GAS). <b>Methods:</b> We used label-free mass spectrometry-based quantitative proteomics to quantify dynamic changes of protein acetylation between gliomas with seizure (CA1 group) and gliomas without seizure (CA2 group). Furthermore, differences of acetyltransferase and deacetylase expression between CA1 and CA2 groups were performed by a quantitative proteomic st ...[more]